C
CureVac
Tubingen, Germany
Founded 2000 NASDAQ: CVAC
About
Pioneer in mRNA technology using lipid nanoparticle delivery for vaccines and therapeutics
Company Details
- Type
- commercial
- Employees
- 500-1000
- Funding
- Public
Key Products
- mRNA Technology Platform